COSCIENS Biopharma Inc. Payments In Respect Of Settlements Net Defined Benefit Liability Asset
COSCIENS Biopharma Inc. (CSCIF) reported Payments In Respect Of Settlements Net Defined Benefit Liability Asset of $896.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Other Cash Flow Items
ifrs-full:PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset · last filed 2026-03-25
- COSCIENS Biopharma Inc. payments in respect of settlements net defined benefit liability asset for the quarter ending 2025-12-31 was $289.00K, a 17.96% increase year-over-year.
- COSCIENS Biopharma Inc. payments in respect of settlements net defined benefit liability asset for the quarter ending 2025-09-30 was $212.00K, a 11.58% increase year-over-year.
- COSCIENS Biopharma Inc. payments in respect of settlements net defined benefit liability asset for the quarter ending 2025-06-30 was $210.00K.
- COSCIENS Biopharma Inc. payments in respect of settlements net defined benefit liability asset for the quarter ending 2025-03-31 was $185.00K, a 1.09% increase year-over-year.
| Period end | Payments In Respect Of Settlements Net Defined Benefit Liability Asset 3 month | Payments In Respect Of Settlements Net Defined Benefit Liability Asset 6 month | Payments In Respect Of Settlements Net Defined Benefit Liability Asset 9 month | Payments In Respect Of Settlements Net Defined Benefit Liability Asset 12 month |
|---|---|---|---|---|
| 2025-12-31 | $289.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $501.00K derived: sum of 2 quarters · filed 2026-03-25 | $711.00K derived: sum of 3 quarters · filed 2026-03-25 | $896.00K 20-F · filed 2026-03-25 |
| 2025-09-30 | $212.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $422.00K derived: sum of 2 quarters · filed 2025-11-12 | $607.00K 6-K · filed 2025-11-12 | $852.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | $210.00K derived: 6-K 6 month − 6-K 3 month · filed 2025-08-14 | $395.00K 6-K · filed 2025-08-14 | $640.00K derived: sum of 3 quarters · filed 2026-03-25 | $830.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | $185.00K 6-K · filed 2025-05-13 | $430.00K derived: sum of 2 quarters · filed 2026-03-25 | $620.00K derived: sum of 3 quarters · filed 2026-03-25 | $498.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | $245.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $435.00K derived: sum of 2 quarters · filed 2026-03-25 | $313.00K derived: sum of 3 quarters · filed 2026-03-25 | $496.00K 20-F · filed 2026-03-25 |
| 2024-09-30 | $190.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $68.00K derived: sum of 2 quarters · filed 2024-11-12 | $251.00K 6-K · filed 2024-11-12 | $506.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | -$122.00K derived: 6-K 6 month − 6-K 3 month · filed 2024-08-13 | $61.00K 6-K · filed 2024-08-13 | $316.00K derived: sum of 3 quarters · filed 2024-08-13 | $496.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | $183.00K 6-K · filed 2024-05-16 | $438.00K derived: sum of 2 quarters · filed 2024-07-17 | $618.00K derived: sum of 3 quarters · filed 2024-07-17 | $804.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2023-12-31 | $255.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $435.00K derived: sum of 2 quarters · filed 2024-07-17 | $621.00K derived: sum of 3 quarters · filed 2024-07-17 | $815.00K 20-F/A · filed 2024-07-17 |
| 2023-09-30 | $180.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-09 | $366.00K derived: sum of 2 quarters · filed 2023-11-09 | $560.00K 6-K · filed 2023-11-09 | $798.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2023-06-30 | $186.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-09 | $380.00K 6-K · filed 2023-08-09 | $618.00K derived: sum of 3 quarters · filed 2024-07-17 | $787.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2023-03-31 | $194.00K 6-K · filed 2023-05-09 | $432.00K derived: sum of 2 quarters · filed 2024-07-17 | $601.00K derived: sum of 3 quarters · filed 2024-07-17 | $780.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2022-12-31 | $238.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $407.00K derived: sum of 2 quarters · filed 2024-07-17 | $586.00K derived: sum of 3 quarters · filed 2024-07-17 | $752.00K 20-F/A · filed 2024-07-17 |
| 2022-09-30 | $169.00K derived: 6-K 9 month − 6-K/A 6 month · filed 2022-11-03 | $348.00K derived: sum of 2 quarters · filed 2022-11-03 | $514.00K 6-K · filed 2022-11-03 | |
| 2022-06-30 | $179.00K derived: 6-K/A 6 month − 6-K 3 month · filed 2022-08-04 | $345.00K 6-K/A · filed 2022-08-04 | ||
| 2022-03-31 | $166.00K 6-K · filed 2022-05-11 | |||
| 2021-12-31 | $511.00K 20-F/A · filed 2024-02-15 | |||
| 2019-09-30 | $96.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-11-07 | $313.00K 6-K · filed 2019-11-07 | ||
| 2019-06-30 | $217.00K 6-K · filed 2019-08-13 | |||
| 2018-12-31 | $494.00K 6-K · filed 2019-11-07 |